Bioorganic & Medicinal Chemistry Letters 2018-04-04

Synthesis of 3-(3-hydroxyphenyl)pyrrolidine dopamine D3 receptor ligands with extended functionality for probing the secondary binding pocket

Anahid Omran, Shakiba Eslamimehr, A. Michael Crider, William L. Neumann

Index: 10.1016/j.bmcl.2018.03.084

Full Text: HTML

Abstract

A series of 3-(3-hydroxyphenyl)pyrrolidine analogues which incorporate N-alkyl groups and N-butylamide-linked benzamide functionality have been synthesized and their in vitro binding affinities at human dopamine receptors have been evaluated. Our ligand design strategy was to take the 3-(3-hydroxyphenyl)pyrrolidine scaffold and extend functionality from the orthosteric binding site to the secondary binding pocket for enhancing affinity and selectivity for the D3 receptor. The N-alkyl analogues constitute a homologous series from N-pentyl to N-decyl to probe the length/bulk tolerance of the secondary binding pocket of the D3 receptor. Enantiomeric 3-(3-hydroxyphenyl)pyrrolidine analogues were also prepared in order to test the chirality preference of the orthosteric binding site for this scaffold. Benzamide analogues were prepared to enhance affinity and/or selectivity based upon the results of the homologous series.

Latest Articles:

Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents

2018-04-11

[10.1016/j.bmcl.2018.04.021]

Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ

2018-04-10

[10.1016/j.bmcl.2018.04.017]

Valproic Acid Induces Three Novel Cytotoxic Secondary Metabolites in Diaporthe sp., an Endophytic Fungus from Datura inoxia Mill

2018-04-10

[10.1016/j.bmcl.2018.04.018]

Agonists of the γ-Aminobutyric Acid Type B (GABAB) Receptor Derived from β-Hydroxy and β-Amino Difluoromethyl Ketones

2018-04-07

[10.1016/j.bmcl.2018.04.003]

Structure-Activity Relationship Study of a Series of Caspase Inhibitors Containing γ-Amino Acid Moiety for Treatment of Cholestatic Liver Disease

2018-04-04

[10.1016/j.bmcl.2018.04.002]

More Articles...